Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01453465
NCT01453465WithdrawnNot Applicable

Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid Tumor (ATRT)

Children's Oncology Group1 site in 1 countryStarted: November 1, 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Molecular differences between RTK and the ATRT
Study OverviewEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT).

OUTLINE:

Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Samples of RTK and ATRT provided by the Children?s Oncology Group (COG)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Molecular differences between RTK and the ATRT

Time Frame: Up to 3 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Biomarkers in Tumor Tissue Samples From Younger Patients With RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaChildhood RhabdomyosarcomaEmbryonal Childhood Rhabdomyosarcoma
NCT01496573Children's Oncology Group77
Completed
Not Applicable
Biomarkers to Distinguish Benign From Malignant Thyroid NeoplasmCancer of the ThyroidNeoplasms, ThyroidThyroid AdenomaThyroid CancerThyroid Carcinoma
NCT01433809Norman Eberhardt1
Terminated
Not Applicable
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney CancerKidney Cancer
NCT00899860Wake Forest University Health Sciences30
Completed
Not Applicable
Biomarkers of Renal Dysfunction in Neuroblastoma SurvivorsNeuroblastoma Survivors
NCT03947346Memorial Sloan Kettering Cancer Center28
Completed
Not Applicable
Validation of Gene Expression Markers of Renal Allograft Functional DeclineKidney Transplant Recipients
NCT01782586National Institute of Allergy and Infectious Diseases (NIAID)499